Detection of blaTEM and blaCTX-M genes by multiplex polymerase chain reaction amongst uropathogenic Escherichia coli strains isolated from hospitalized patients in Kolkata, India
Bush, K. 2002. The impact of beta-lactamases on the development of novel antimicrobial agents. Current Opinion Investigative Drugs 3,1284–1290.
Clinical Laboratory Standards Institute 2006. Performance standards for antimicrobial disc susceptibility tests, XVI international Supplement (M100-S16). Wayne Pa, USA: National Committee for Clinical Laboratory Standards.
Harada S, Ishii Y, Yamaguchi K. 2008. Extended-spectrum β- Lactamases: Implications for the Clinical Laboratory and Therapy. Korean Journal of Laboratory Medine 28, 401-412.
Hosoglu S, Gundes S, Kolayh F, Karadenizli A, Demirdag K, Gunaydm M, Altmdis M, Caylan R, Uemak H. 2007. Extended-spectrum β-Lactamases in ceftazidime resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals. Indian Journal of Medical Microbiology 25, 346-350.
Jemima SA, Varghese S. 2008. Multiplex PCR for blaCTX-M & blaSHV in the extended spectrum beta lactamase (ESBL) producing Gram-negative isolates Indian Journal of Medical Research 128, 313-317.
Kahan NR, Chinitz DP, Waitman DA, Dushnitzky D, Kahan E, Shapiro M. 2006. Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: another lost treatment option? Annals of Pharmacotherapy 40, 2223-2227.
Kumar MS, Lakshmi V, Rajagopalan R. 2006. Occurrence of extended spectrum beta-lactamases among Enterobacteriaceae spp. isolated at a tertiary care institute. Indian Journal of Medical Microbiology 24, 208-211.
Manges AR, Natarajan P, Solberg OD, Dietrich PS, Riley LW. 2006. The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiology Infection 134, 425-431.
Moura A, Nicolau A, Hooton T, Azeredo J. 2009. Antibiotherapy and pathogenesis of uncomplicated difficult relationships UTI : Journal of Applied Microbiology 106, 1779–1791.
Myer and Koshi. 2001. Methods in biochemical identification of bacteria. Myer’s and Koshi’s manual of diagnostic procedures in medical microbiology and immunology/ serology, 2nd ed. Vellore: Department of Clinical Microbiology, Christian Medical College 195-202.
Navon-Vanenzia S, Hammer-Munz O, Schwartz D, Turner D, Kuzmenko B, Carmeli Y. 2003. Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. Journal of Clinical Microbiology 41, 155-158.
Paterson DL, Yu VL. 1999. Extended spectrum beta lactamases: a call for improved detection and control. Clinical Infectious Diseases 29, 1419-22.
Perez F, Endimiani A, Hujer KM, Bonomo RA. 2007. The continuing challenge of ESBLs. Current Opinion in Pharmacology 7, 459–469.
Sambrook J, Fritsch EF, Maniatis T. 2001. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, New York, USA.
Sharma J, Sharma M, Ray P. 2010. Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian Journal of Medical Research 132, 332-336.